Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 36: 1625-1628, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fraser, C. G.
Right arrow Articles by Larsen, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fraser, C. G.
Right arrow Articles by Larsen, M. L.

Clinical Chemistry, Vol 36, 1625-1628, Copyright © 1990 by American Association for Clinical Chemistry

Setting analytical goals for random analytical error in specific clinical monitoring situations

CG Fraser, P Hyltoft Peterson and ML Larsen
Department of Biochemical Medicine, Ninewells Hospital and Medical School, Dundee, Scotland.

Strategies abound for the setting of analytical goals in clinical chemistry. Many, especially those more recently proposed for particular clinical situations, are concerned with tests used in diagnosis. We suggest a general theory for the setting of goals in situations that specifically involve the monitoring of individuals. Goals are calculated from the formula CVA less than [(delta c 2/2Z2)-CVB2]1/2, where CVA is the analytical imprecision (as coefficient of variation, CV); delta c is the percentage change in serial results that is considered clinically significant; Z is the Z-statistic, which depends only on the probability selected for statistical significance; and CVB is the average inherent within-subject biological variation (as CV). Examples given show applications in hematology and in monitoring diabetes mellitus, chronic renal failure, and hepatitis. The derived goals are for total random analytical error (imprecision and intermittent systematic variation), and provide objective criteria that should be achieved in practice. The effect of analytical variability on both variability in test results and the probability that a stated change can be considered significant should be calculated whether or not the goals are attained.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
A.-H. Kristoffersen, G. Thue, and S. Sandberg
Postanalytical External Quality Assessment of Warfarin Monitoring in Primary Healthcare
Clin. Chem., October 1, 2006; 52(10): 1871 - 1878.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. R. D. Jones
Effect of the Reporting-Interval Size on Critical Difference Estimation: Beyond "2.77"
Clin. Chem., May 1, 2006; 52(5): 880 - 885.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Soletormos, A. Semjonow, P. E.C. Sibley, R. Lamerz, P. H. Petersen, W. Albrecht, P. Bialk, M. Gion, F. Junker, H.-P. Schmid, et al.
Biological Variation of Total Prostate-Specific Antigen: A Survey of Published Estimates and Consequences for Clinical Practice
Clin. Chem., August 1, 2005; 51(8): 1342 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Meijer, M. P.M. de Maat, C. Kluft, F. Haverkate, and H. C. van Houwelingen
Long-Term Analytical Performance of Hemostasis Field Methods as Assessed by Evaluation of the Results of an External Quality Assessment Program for Antithrombin
Clin. Chem., July 1, 2002; 48(7): 1011 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Biosca, C. Ricos, R. Lauzurica, R. Galimany, and P. Hyltoft Petersen
Reference Change Value Concept Combining Two Delta Values to Predict Crises in Renal Posttransplantation
Clin. Chem., December 1, 2001; 47(12): 2146 - 2148.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Soletormos and V. Schioler
Description of a Computer Program to Assess Cancer Antigen 15.3, Carcinoembryonic Antigen, and Tissue Polypeptide Antigen Information during Monitoring of Metastatic Breast Cancer
Clin. Chem., August 1, 2000; 46(8): 1106 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Soletormos, P. Hyltoft Petersen, and P. Dombernowsky
Progression Criteria for Cancer Antigen 15.3 and Carcinoembryonic Antigen in Metastatic Breast Cancer Compared by Computer Simulation of Marker Data
Clin. Chem., July 1, 2000; 46(7): 939 - 949.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Gibb, A. Parnham, M. Fonfrede, and F. Lecock
Multicenter Evaluation of Tosoh Glycohemoglobin Analyzer
Clin. Chem., October 1, 1999; 45(10): 1833 - 1841.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. E. Huffstutter, P. M. Fischer, R. L. Black, M. H. Field, J. A. Kasch, J. S. Kroger, P. D. Rappo, P. B. Harr, L. H. Hilborne, and T. M. St John
Accuracy of Physicians' Office Laboratory Results
JAMA, July 8, 1998; 280(2): 129 - 132.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.